新冠疫苗接种后灼口综合征：一例报告
Burning Mouth Syndrome Following Covid Vaccination: A Case Report.
作者信息
Broachwala Mustafa, Banks Dylan W, Jevotovsky David S, Oehlermarx Whitman, Durbhakula Shravani
机构信息
Department of Anesthesiology and Pain University of California San Diego San Diego California USA.
Department of Physical Medicine and Rehabilitation New York University New York New York USA.
出版信息
Clin Case Rep. 2025 Apr 29;13(5):e70329. doi: 10.1002/ccr3.70329. eCollection 2025 May.
Abstract
This is the first reported case of burning mouth syndrome resulting from the Pfizer-BioNTech COVID-19 vaccine. It highlights the efficacy of a unique multimodal treatment regimen, including zinc supplementation, acupuncture, and topical capsaicin.
摘要
这是首例报告的由辉瑞-生物科技公司新冠疫苗导致的灼口综合征病例。它凸显了一种独特的多模式治疗方案的疗效，该方案包括补充锌、针灸和局部使用辣椒素。
相似文献
1
Burning Mouth Syndrome Following Covid Vaccination: A Case Report.新冠疫苗接种后灼口综合征：一例报告
Clin Case Rep. 2025 Apr 29;13(5):e70329. doi: 10.1002/ccr3.70329. eCollection 2025 May.
2
Vitamin B and Zinc Supplements and Capsaicin Oral Rinse Treatment Options for Burning Mouth Syndrome.维生素B和锌补充剂以及辣椒素口腔冲洗液治疗灼口综合征的选择
Medicina (Kaunas). 2021 Apr 17;57(4):391. doi: 10.3390/medicina57040391.
3
Bullous pemphigoid after second dose of mRNA- (Pfizer-BioNTech) Covid-19 vaccine: A case report.第二剂mRNA（辉瑞-生物科技公司）新冠疫苗接种后发生大疱性类天疱疮：一例报告。
Ann Med Surg (Lond). 2022 Mar;75:103420. doi: 10.1016/j.amsu.2022.103420. Epub 2022 Mar 1.
4
Exploring the adverse events of Oxford-AstraZeneca, Pfizer-BioNTech, Moderna, and Johnson and Johnson COVID-19 vaccination on Guillain-Barré Syndrome.探讨牛津-阿斯利康、辉瑞-BioNTech、莫德纳和强生 COVID-19 疫苗接种对吉兰-巴雷综合征的不良事件。
Sci Rep. 2024 Aug 13;14(1):18767. doi: 10.1038/s41598-024-66999-7.
5
COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.COVID-19 疫苗：辉瑞/生物科技和 Moderna 疫苗的生物学、药理学特征和不良反应比较。
Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1663-1669. doi: 10.26355/eurrev_202102_24877.
6
Guillain-Barre syndrome following Pfizer-BioNTech (BNT162b2) vaccination: a case report.辉瑞-BioNTech（BNT162b2）疫苗接种后发生吉兰-巴雷综合征：一例报告
Ann Med Surg (Lond). 2024 May 20;86(11):6693-6695. doi: 10.1097/MS9.0000000000002197. eCollection 2024 Nov.
7
[Comparative Analyses of IgA Antibody Response of Non-COVID-19 Infected People Over 60 Years Old Following CoronaVac and Pfizer-BioNTech COVID-19 Vaccination].60岁以上未感染新冠病毒人群接种科兴新冠疫苗和辉瑞-BioNTech新冠疫苗后IgA抗体反应的比较分析
Mikrobiyol Bul. 2023 Apr;57(2):330-333. doi: 10.5578/mb.20239927.
8
Increasing Levels of Serum Anti-Spike S1-RBD IgG after 120 Days of the Pfizer-BioNTech-mRNA Second Dose Vaccination.辉瑞-生物科技 mRNA 疫苗第二剂接种 120 天后血清抗刺突 S1-RBD IgG 水平升高。
Arch Razi Inst. 2023 Jun 30;78(3):1071-1075. doi: 10.22092/ARI.2022.359934.2517. eCollection 2023 Jun.
9
Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12-18 Years - United States, July-December 2021.辉瑞-生物科技的 BNT162b2 (Pfizer-BioNTech) mRNA 疫苗在 12-18 岁人群中预防儿童多系统炎症综合征的有效性-美国，2021 年 7 月至 12 月。
MMWR Morb Mortal Wkly Rep. 2022 Jan 14;71(2):52-58. doi: 10.15585/mmwr.mm7102e1.
10
Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.在报告 Janssen（强生）和 mRNA COVID-19 疫苗（辉瑞-生物科技和莫德纳）成年受种者发生不良事件后使用 COVID-19 疫苗：免疫实践咨询委员会的更新-美国，2021 年 7 月。
MMWR Morb Mortal Wkly Rep. 2021 Aug 13;70(32):1094-1099. doi: 10.15585/mmwr.mm7032e4.
本文引用的文献
1
Chronic oral diseases secondary to COVID-19 infection or vaccination: clinical cases and a narrative review.新型冠状病毒肺炎感染或疫苗接种继发的慢性口腔疾病：临床病例及叙述性综述
Quintessence Int. 2024 May 30;55(5):400-411. doi: 10.3290/j.qi.b5031811.
2
COVID-19 Vaccination and Neurological Manifestations: A Review of Case Reports and Case Series.COVID-19疫苗接种与神经系统表现：病例报告及病例系列综述
Brain Sci. 2022 Mar 18;12(3):407. doi: 10.3390/brainsci12030407.
3
Various painful oral adverse reactions following COVID-19 vaccination: a case series.接种 COVID-19 疫苗后出现的各种口腔疼痛不良反应：病例系列研究。
BMC Oral Health. 2022 Mar 8;22(1):64. doi: 10.1186/s12903-022-02100-w.
4
A Novel Case of Bifacial Diplegia Variant of Guillain-Barré Syndrome Following Janssen COVID-19 Vaccination.接种杨森新冠疫苗后发生吉兰-巴雷综合征双侧面瘫变异型的一例新病例。
Neurol Int. 2021 Aug 13;13(3):404-409. doi: 10.3390/neurolint13030040.
5
Electromyoneurography and laboratory findings in a case of Guillain-Barré syndrome after second dose of Pfizer COVID-19 vaccine.肌电图神经电图检查和实验室检查在第二剂辉瑞 COVID-19 疫苗接种后发生的格林-巴利综合征病例中的表现。
Hum Vaccin Immunother. 2021 Nov 2;17(11):4093-4096. doi: 10.1080/21645515.2021.1954826. Epub 2021 Aug 4.
6
Acute disseminated encephalomyelitis after SARS-CoV-2 vaccination.接种 SARS-CoV-2 疫苗后出现急性播散性脑脊髓炎。
Clin Neurol Neurosurg. 2021 Sep;208:106839. doi: 10.1016/j.clineuro.2021.106839. Epub 2021 Jul 21.
7
Sequential contralateral facial nerve palsies following COVID-19 vaccination first and second doses.序贯接种新冠疫苗后出现双侧面瘫。
BMJ Case Rep. 2021 Jul 19;14(7):e243829. doi: 10.1136/bcr-2021-243829.
8
Post-COVID-19 vaccine Guillain-Barré syndrome; first reported case from Qatar.新冠疫苗接种后格林-巴利综合征；卡塔尔首例报告病例。
Ann Med Surg (Lond). 2021 Jul;67:102540. doi: 10.1016/j.amsu.2021.102540. Epub 2021 Jul 3.
9
Unique Imaging Findings of Neurologic Phantosmia Following Pfizer-BioNtech COVID-19 Vaccination: A Case Report.辉瑞-生物科技 COVID-19 疫苗接种后神经幻嗅的独特影像学表现：一例报告。
Top Magn Reson Imaging. 2021 Jun 1;30(3):133-137. doi: 10.1097/RMR.0000000000000287.
10
Facial and Oral Manifestations Following COVID-19 Vaccination: A Survey-Based Study and a First Perspective.接种 COVID-19 疫苗后面部和口腔表现：一项基于调查的研究和初步观察。
Int J Environ Res Public Health. 2021 May 7;18(9):4965. doi: 10.3390/ijerph18094965.
Zotero 插件